首页> 外文期刊>Lancet Neurology >Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial
【24h】

Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial

机译:微创手术加阿替普酶在脑出血撤离(MISTIE)中的安全性和有效性:一项随机,对照,开放标签的2期临床试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background Craniotomy, according to the results from trials, does not improve functional outcome after intracerebral haemorrhage. Whether minimally invasive catheter evacuation followed by thrombolysis for dot removal is safe and can achieve a good functional outcome is not known. We investigated the safety and efficacy of alteplase, a recombinant tissue plasminogen activator, in combination with minimally invasive surgery (MIS) in patients with intracerebral haemorrhage.
机译:根据试验结果,背景颅骨切开术并不能改善脑出血后的功能预后。目前尚不知道微创导管排空后再进行溶栓去除是否安全并且能否获得良好的功能预后。我们研究了阿替普酶(重组组织纤溶酶原激活剂)与脑出血患者微创手术(MIS)结合的安全性和有效性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号